The plain-language read
Acne Vulgaris (Acne) is a common, chronic, cutaneous disorder associated with scarring, hyperpigmentation, and adverse psychological effects. Isotretinoin is considered to be the most effective treatment for the management of severe acne; however, issues remain with inequitable access to this drug.
- Isotretinoin is considered to be the most effective treatment for the management of severe acne; however, issues remain with inequitable access to this drug.
Relevant if you're working with retinol, pha for acne and hyperpigmentation.
What this means for your routine
If you're targeting acne, this research supports adding retinol to your PM routine.
If you're targeting acne, this research supports adding pha to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
1. HRB Open Res. 2026 Feb 26;9:21. doi: 10.12688/hrbopenres.14215.1. eCollection 2026. The Management of Acne in General Practice using Isotretinoin: A Scoping Review Protocol. Collins S(1), Foley T(1), Quinlan D(1)(2), Wallace E(1), Sahm L(3), Farrell A(1).
Full abstract→
1. HRB Open Res. 2026 Feb 26;9:21. doi: 10.12688/hrbopenres.14215.1. eCollection 2026. The Management of Acne in General Practice using Isotretinoin: A Scoping Review Protocol. Collins S(1), Foley T(1), Quinlan D(1)(2), Wallace E(1), Sahm L(3), Farrell A(1). Author information: (1)Department of General Practice, University College Cork School of Medicine, Cork, County Cork, Ireland. (2)Irish College of General Practitioners, Dublin, Ireland. (3)Pharmaceutical Care Research Group, School of Pharmacy, University College Cork School of Medicine, Cork, County Cork, Ireland. INTRODUCTION: Acne Vulgaris (Acne) is a common, chronic, cutaneous disorder associated with scarring, hyperpigmentation, and adverse psychological effects. The high prevalence of acne places a significant burden on healthcare systems worldwide due to the cost of treatment. The high usage of antibiotics in the treatment of this condition also has a significant impact on the prevalence of antimicrobial resistance. Isotretinoin is considered to be the most effective treatment for the management of severe acne; however, issues remain with inequitable access to this drug. General Practitioners (GPs) are ideally placed to identify and manage patients with moderate-to-severe acne; however, in many countries the prescription of isotretinoin is limited to secondary care. To the authors' knowledge, no review has been conducted to identify, map and analyse literature pertaining to GPs' use of isotretinoin for the management of acne. METHODS: As recommended by the Joanna Briggs Institute (JBI), a three-step search strategy will be utilised for this scoping review. A search strategy will be developed using key words, search terms and controlled vocabulary suitable for each literature source. Both primary and grey literature will be eligible for inclusion in this review. Identified literature will be screened by two reviewers to identify relevant evidence. The full-text sources will then be evaluated by two independent researchers to extract relevant data. The findings of this review will be reported as a descriptive summary accompanied by a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. RESULTS: This scoping review protocol outlines a systematic approach to map a broad range of sources and summarise existing evidence regarding GPs' use of isotretinoin for the management of acne in primary care. CONCLUSIONS: The objective of this scoping review is to comprehensively identify, map, and analyse literature pertaining to the management of acne using isotretinoin in general practice. REVIEW REGISTRATION: Registered on Open Science Framework on 02/10/2025 ( https://osf.io/rak3d/). Copyright: © 2026 Collins S et al. DOI: 10.12688/hrbopenres.14215.1 PMCID: PMC13241837 PMID: 42256234 Conflict of interest statement: No competing interests were disclosed.
Original source →Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.
Friedreich's ataxia is a rare, chronic, progressive, neurodegenerative condition affecting multiple organ systems, including neurological, musculoskeletal, cardiac, and endocrine systems, and is marked by low cardiopulmonary fitness. We tested the effect of exercise and NAD+ precursor supplementation with nicotinamide riboside, which have each shown benefits in animal and early clinical studies, on cardiopulmonary fitness in individuals with Friedreich's ataxia. This 12-week, outpatient, phase 2, single-site (Children's Hospital of Philadelphia, Philadelphia, PA, USA), randomised, 2 × 2 factorial clinical trial recruited individuals aged 10-40 years with an ejection fraction of 45% or greater who were able to exercise.
Does Astragalus mongholicus Bunge help promote the healing of wounds? A systematic review and meta-analysis of preclinical animal studies.
Wounds continue to represent a significant public health challenge globally. In recent years, Astragalus mongholicus Bunge, a traditional Chinese botanical drug utilized for wound treatment, has garnered increasing research attention. However, the therapeutic efficacy and safety of this natural botanical drug on wound healing remain poorly understood.
Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.
Recent preclinical studies have shown that nicotinamide adenine dinucleotide (NAD+) plays a critical role in molecular mechanisms of axon degeneration, and reductions in NAD+ levels are associated with axonal degeneration. Nicotinamide riboside (NR) is a safe and widely available pyridine-nucleoside form of vitamin B3 and is an NAD+ precursor. To investigate if oral supplementation of synthetic NR can act as a therapeutic agent to prevent degeneration of small somatic sensory axons innervating the skin or promote regeneration of these same fibers in humans, we utilized a validated experimental model of cutaneous nerve degeneration and regeneration and conducted a placebo-controlled, double-blinded Phase 2 study.